Chris Przybyszewski
U.S. Biologic, Inc. is a privately held company located in Memphis, Tennessee, and was founded in December 2012. The company focuses on integrating vaccines and therapeutics into its oral-delivery technology platform.[1] The company also develops big data, preventative analytics[2] toolsets to proactively identify potential disease hotspots and guide disease prevention programs.
One of U.S. Biologic's current products is an orally delivered Lyme disease[3] vaccine[4] that targets the main reservoir for the disease, Peromyscus Leucopus[5] (i.e., the white-footed mouse).
References[edit]
- ↑ http://www.usbiologic.com. Retrieved 10 January 2018. Missing or empty
|title=
(help) - ↑ "Predictive analytics". Retrieved 10 January 2018.
- ↑ "Lyme disease". Retrieved 10 January 2018.
- ↑ "The growing global battle against blood-sucking ticks". Nature. Retrieved 10 January 2018.
- ↑ White-footed mouse https://en.wikipedia.org/wiki/White-footed_mouse. Retrieved 10 January 2018. Missing or empty
|title=
(help)
U.S. BIologic, Inc.[edit]
This article "Chris Przybyszewski" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Chris Przybyszewski. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.